GTX Genetix Grp

 

TIDMGTX 
 
RNS Number : 6001S 
Genetix Group PLC 
21 May 2009 
 

Genetix Group plc 
 
 
=-AGM Statement-- 
 
 
New Milton, UK, 21 May 2009 - Genetix Group plc (AIM:GTX), the cell imaging and 
analysis group will hold its Annual General Meeting (AGM) today at 11.30 a.m. 
 
 
During the course of the meeting Charles de Rohan, Chief Executive of Genetix, 
will make the following statement to shareholders: 
 
 
"Genetix has made a positive start to the year and is trading in line with our 
expectations. 
While no company is immune from the effects of the global economic conditions, 
our tightly managed business coupled with our products delivering tangible 
benefits to our customers, is proving resilient in meeting these challenges. 
The successful rebalancing of our product portfolio over the last few years 
means the Group is in a strong position to capitalise on the growth within its 
chosen markets of biopharmaceutical drug discovery and diagnostics - markets 
which allow us to play to our strengths in imaging and intelligent analysis. 
We are excited about the opportunities that our recent acquisition of SlidePath 
present, allowing us to accelerate and strengthen our presence in the growing 
digital pathology market. Combining SlidePath's cutting edge products and 
technologies with our sales and customer support infrastructure in Europe, the 
United States and Japan, along with our strong customer relationships with 
diagnostics and pharmaceutical companies will enhance our position in this 
exciting market." 
=-Ends-- 
 
 
+------------------------------------+------------------------------------+ 
| Genetix Group plc                  |                                    | 
+------------------------------------+------------------------------------+ 
| Charles de Rohan, Chief Executive  | Tel: +44 (0) 1425 624600           | 
+------------------------------------+------------------------------------+ 
| Andrew Kellett, Finance Director   |                                    | 
+------------------------------------+------------------------------------+ 
|                                    |                                    | 
+------------------------------------+------------------------------------+ 
| Financial Dynamics                 |                                    | 
+------------------------------------+------------------------------------+ 
| Jonathan Birt / Susan Quigley      | Tel: +44 (0) 20 7831 3113          | 
+------------------------------------+------------------------------------+ 
|                                    |                                    | 
+------------------------------------+------------------------------------+ 
| Piper Jaffray Ltd.                 |                                    | 
+------------------------------------+------------------------------------+ 
| James Steel                        | Tel: +44 (0) 20 3142 8700          | 
+------------------------------------+------------------------------------+ 
 
 
 
 
The release will be available on the Company's website: www.genetix.com 
 
 
 
 
Notes to Editors 
 
 
About Genetix Group plc 
 
 
Headquartered in New Milton, UK, with offices in the UK, US, Germany, Ireland 
and Japan, and quoted on the AIM (GTX: AIM), Genetix provides scientists and 
clinicians with unrivalled solutions for imaging and intelligent image analysis 
in the life science and diagnostic markets. 
In life sciences, the company's systems set industry standards for accurate 
selection of microbial colonies, and for screening and selection of mammalian 
secretory cell lines. Other systems evaluate the response of cells to potential 
therapeutic agents and quantify tissue biomarkers. 
In diagnostics, Genetix holds a leading position in genetic testing with 
thousands of the company's platforms used in laboratories worldwide. 
Through its expertise in robotics, cell and molecular biology, image analysis 
and interpretation, supported by a strong IP portfolio, Genetix is committed to 
the continual development of innovative solutions. 
 
 
 
 
 
 
 
 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 AGMAMMATMMTTBPL 
 

Genetix Grp (LSE:GTX)
Gráfica de Acción Histórica
De May 2024 a Jun 2024

Genetix Grp (LSE:GTX)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024